Fundz

Real-time funding, M&A, exec moves & hiring — the signals that move deals

More real-time opportunities that match your ICP — every funding, M&A, and exec move the moment it breaks, with the verified contacts to reach out first.

The funding market, moving in real timeBook a DemoChoose your plan
Loading live signals…

Funding, M&A, exec moves & hiring — every signal Fundz sees, the moment it happens. See who’s in your market, who to reach, and why now.

Back to SEC Filings
Executive ChangeItem 5.02 · 8-KMEDIUM RiskPositive

agilon health, inc.

Filed: Apr 24, 2026CIK: 0001831097
Watch CompanyView on SEC.gov

AI Executive Summary

AI-powered analysis of 8-K filing content

Agilon Health appointed Tim O'Rourke as Chief Executive Officer and President, effective May 7, 2026, signaling a leadership transition that aims to strengthen the company's strategic direction in the healthcare sector.

Key Takeaways

Tim O'Rourke will assume the role of CEO and President, reporting directly to the Board of Directors

O'Rourke will also join the Board as a Class III director effective on his commencement date

2 more takeaways

Related Filings (1)

1 more filing from agilon health, inc. in the last 90 days

Filing Overview

Form Type8-K
Filing DateApr 24, 2026
Item5.02
CategoryExecutive Change
CIK0001831097
Accession #agl-20260424
Risk LevelMEDIUM
SentimentPositive
Signalinformational
Topics
executive hireleadership transitionboard change

What This Means

A senior executive (CEO, CFO, etc.) has joined, departed, or changed roles. Leadership changes can significantly impact strategy.
View Full Filing on SEC.govBrowse More Filings